Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register

McCarthy, EM, Sutton, E, Nesbit, S et al. (18 more authors) (2018) Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register. Rheumatology, 57 (3). pp. 470-479. ISSN 1462-0324

Abstract

Metadata

Authors/Creators:
  • McCarthy, EM
  • Sutton, E
  • Nesbit, S
  • White, J
  • Parker, B
  • Jayne, D
  • Griffiths, B
  • Isenberg, DA
  • Rahman, A
  • Gordon, C
  • D'Cruz, DP
  • Rhodes, B
  • Lanyon, P
  • Vital, EM https://orcid.org/0000-0003-1637-4755
  • Yee, C-S
  • Edwards, CJ
  • Teh, L-S
  • Akil, M
  • McHugh, NJ
  • Zoma, A
  • Bruce, IN
Copyright, Publisher and Additional Information: © 2017, The Author. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Keywords: systemic lupus erythematosus; biologic therapy; rituximab; register
Dates:
  • Published: 1 March 2018
  • Accepted: 27 September 2017
  • Published (online): 5 December 2017
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 25 Sep 2018 14:30
Last Modified: 25 Sep 2018 14:30
Status: Published
Publisher: Oxford University Press
Identification Number: https://doi.org/10.1093/rheumatology/kex395

Share / Export

Statistics